Clinical operations field note

Clinical Operations Planning After a Positive Oncology Readout

Prepare clinical operations for cohort expansion, new sites, vendor changes, and pivotal trial planning after a positive oncology readout.

By Lampgen Clinical Research

1 min read · estimated

A POSITIVE READOUT CAN CHANGE THE WORKLOAD OVERNIGHT.

A positive oncology readout does more than validate the scientific hypothesis.

It can trigger expansion cohorts, pivotal planning, new sites, additional vendors, regulatory activity, data-cleaning pressure, and a more demanding governance cadence.

The program may be moving forward with the same Clinical Operations team that was built for an earlier stage.

That is where capacity risk develops.

Before the next phase begins, sponsors should reassess:

• CTM study load • monitoring coverage • site startup support • vendor oversight • TMF readiness • transition and onboarding time

Scientific momentum should be matched by an operational plan capable of carrying it.

AVAILABLE FOR NEW PARTNERSHIPS

What does your clinical team need next?